These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12957688)

  • 41. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
    Nanjee MN; Cooke CJ; Olszewski WL; Miller NE
    J Lipid Res; 2000 Aug; 41(8):1317-27. PubMed ID: 10946020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L
    Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations.
    Holleboom AG; Kuivenhoven JA; Peelman F; Schimmel AW; Peter J; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Motazacker MM
    Hum Mutat; 2011 Nov; 32(11):1290-8. PubMed ID: 21901787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial lecithin-cholesterol acyltransferase deficiency in a Japanese family: evidence for functionally defective enzyme in homozygotes and obligate heterozygotes.
    Albers JJ; Chen CH; Adolphson J; Sakuma M; Kodama T; Akanuma Y
    Hum Genet; 1982; 62(1):82-5. PubMed ID: 7152525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.
    Holleboom AG; Daniil G; Fu X; Zhang R; Hovingh GK; Schimmel AW; Kastelein JJ; Stroes ES; Witztum JL; Hutten BA; Tsimikas S; Hazen SL; Chroni A; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3066-75. PubMed ID: 23023370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular analysis of a novel LCAT mutation (Gly179 → Arg) found in a patient with complete LCAT deficiency.
    Wang XL; Osuga J; Tazoe F; Okada K; Nagashima S; Takahashi M; Ohshiro T; Bayasgalan T; Yagyu H; Okada K; Ishibashi S
    J Atheroscler Thromb; 2011; 18(8):713-9. PubMed ID: 21597230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease.
    Funke H; von Eckardstein A; Pritchard PH; Hornby AE; Wiebusch H; Motti C; Hayden MR; Dachet C; Jacotot B; Gerdes U
    J Clin Invest; 1993 Feb; 91(2):677-83. PubMed ID: 8432868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.
    Bruckert E; von Eckardstein A; Funke H; Beucler I; Wiebusch H; Turpin G; Assmann G
    Atherosclerosis; 1997 Jan; 128(1):121-8. PubMed ID: 9051205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
    Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM
    J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel TC deletion resulting in Pro(260)-->Stop in the human LCAT gene is associated with a dominant effect on HDL-cholesterol.
    Kasid A; Rhyne J; Zeller K; Pritchard H; Miller M
    Atherosclerosis; 2001 May; 156(1):127-32. PubMed ID: 11369005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective enzyme causes lecithin-cholesterol acyltransferase deficiency in a Japanese kindred.
    Albers JJ; Adolphson J; Chen CH; Murayama N; Honma S; Akanuma Y
    Biochim Biophys Acta; 1985 Jul; 835(2):253-7. PubMed ID: 4005283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lecithin: cholesterol acyltransferase (LCAT)--the genetic analysis of familial LCAT deficiency and fish eye disease].
    Bujo H; Saito Y
    Nihon Rinsho; 1995 May; 53(5):1260-6. PubMed ID: 7602789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins.
    Zhao Y; Thorngate FE; Weisgraber KH; Williams DL; Parks JS
    Biochemistry; 2005 Jan; 44(3):1013-25. PubMed ID: 15654758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two novel molecular defects in the LCAT gene are associated with fish eye disease.
    Kuivenhoven JA; Stalenhoef AF; Hill JS; Demacker PN; Errami A; Kastelein JJ; Pritchard PH
    Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):294-303. PubMed ID: 8620346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
    Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
    Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment.
    Naito S; Kamata M; Furuya M; Hayashi M; Kuroda M; Bujo H; Kamata K
    Atherosclerosis; 2013 May; 228(1):193-7. PubMed ID: 23522979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states.
    Asztalos BF; Schaefer EJ; Horvath KV; Yamashita S; Miller M; Franceschini G; Calabresi L
    J Lipid Res; 2007 Mar; 48(3):592-9. PubMed ID: 17183024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.